Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing the Use of Proviral DNA HIV Drug Resistance Testing: Clinical Applications and Cautions.

The Journal of infectious diseases·2026
Same author

Optimizing HIV-1 Genotypic Resistance Testing for Low- and Middle-Income Countries: High-Impact HIV-1 Mutations Across WHO-Defined Scenarios.

Viruses·2026
Same author

SliceMap: a binary classification-driven 2D pipeline for detecting discriminative candidate regions in brain MRI.

Frontiers in neuroimaging·2026
Same author

Letter to the editor: When do rare events become expected in HIV drug resistance?

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Dynamic case-control sampling for rapid estimation of vaccine effectiveness against an emerging infectious disease variant.

Biostatistics (Oxford, England)·2026
Same author

Longitudinal challenges faced by perinatally-infected young people with HIV in Kenya during the COVID-19 pandemic.

AIDS (London, England)·2026

Related Experiment Video

Updated: May 29, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Sequence quality analysis tool for HIV type 1 protease and reverse transcriptase.

Allison K Delong1, Mingham Wu, Diane Bennett

  • 1Center for Statistical Sciences, Brown University, Providence, Rhode Island 02906, USA.

AIDS Research and Human Retroviruses
|September 16, 2011
PubMed
Summary
This summary is machine-generated.

A new tool, HIV PR/RT Sequence Quality Analysis Tool (SQUAT), ensures high-quality sequences for HIV drug resistance testing. This free, web-independent software aids in accurate interpretation and reporting of treatment resistance.

More Related Videos

Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells
13:07

Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells

Published on: January 30, 2019

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

Related Experiment Videos

Last Updated: May 29, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells
13:07

Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells

Published on: January 30, 2019

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

Area of Science:

  • * Computational biology
  • * Virology
  • * Bioinformatics

Background:

  • * Increasing global access to antiretroviral therapy (ART) necessitates robust monitoring for drug resistance.
  • * The generation of protease (PR) and reverse transcriptase (RT) sequences is rising, demanding rigorous quality assessment.
  • * In-house sequencing assays require reliable methods for quality control before analysis.

Purpose of the Study:

  • * To develop a computational tool, the HIV PR/RT Sequence Quality Analysis Tool (SQUAT), for assessing the quality of HIV PR/RT sequences.
  • * To establish quality thresholds based on extensive datasets from published literature.
  • * To provide a user-friendly, free, and web-independent solution for sequence quality control.

Main Methods:

  • * SQUAT was developed within the R statistical environment.
  • * Quality thresholds were derived from a large dataset of 46,802 PR and 44,432 RT sequences.
  • * The tool processes nucleic acid sequences, identifies, aligns, translates them, and flags sequences based on predefined quality criteria (insertions, deletions, ambiguous bases, mutations, stop codons, genetic distance).

Main Results:

  • * SQUAT successfully flags sequences with potential quality issues based on defined criteria.
  • * The tool generates comprehensive reports including troubleshooting comments, genetic distance histograms, and phylogenetic trees.
  • * User-modifiable thresholds allow for adaptation to specific research or clinical needs.

Conclusions:

  • * SQUAT is a valuable, free, and stand-alone tool for ensuring the quality of HIV PR/RT sequences.
  • * It enhances the accuracy of HIV drug resistance interpretation and reporting.
  • * The tool promotes expertise and facilitates troubleshooting of problematic sequences in HIV treatment monitoring.